Europe
Asia
Oceania
Americas
Africa
HEALTH
How GLP-1drugs like MOUNJARO and OZEMPIC are rede
Would she live happily ever after (the jabs)?
We’ve all heard of Ozempic by now. It’s only licensed for use as an injectable diabetes treatment in the UK and US, but it’s widely used ‘off label’ to help people lose weight. So much so in fact, tha
Body confidence is at a crossroads. The everyday conversation around weight and appearance has shifted from supermodels and diet clubs, and is now dominated by weight-loss drugs, biohacking and viral
From those lacing up their trainers after losing weight to anyone considering medication as a route to faster race times, the use of GLP-1s in the running community is on the rise. But weighing any potential benefits with the inherent dangers is a delicate balancing act
MULTIPLYING WEIGHT-LOSS MEDS WHEN MIKE DOUSTDAR STARTED AS A SUMMER EMPLOYEE making copies at Novo Nordisk—a teenager living in Austria after fleeing unrest in his home country of Iran at 12—he never
Around 2.5 million people are currently taking weight-loss drugs in the UK. That’s almost 3.5% of the population injecting drugs such as Mounjaro and WeGovy and facing up to access barriers, price fluctuations and supply shortages. But, as four men explain, the hype around these drugs is very real